nimorazole
Sign in to saveNimorazole (INN) is a nitroimidazole anti-infective. It is also being investigated for the treatment of head and neck cancer.
Research
159 papers- Transcriptomic and epigenetic landscape of nimorazole-enhanced radiochemotherapy in head and neck cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2024
- Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts.Journal of translational medicine · 2023
- Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD).International journal of radiation oncology, biology, physics · 2024
- (15) N NMR Hyperpolarization of Radiosensitizing Antibiotic Nimorazole by Reversible Parahydrogen Exchange in Microtesla Magnetic Fields.Angewandte Chemie (International ed. in English) · 2021
- NIMRAD - a phase III trial to investigate the use of nimorazole hypoxia modification with intensity-modulated radiotherapy in head and neck cancer.Clinical oncology (Royal College of Radiologists (Great Britain)) · 2014
via PubMed
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Nimorazole (INN) is a nitroimidazole anti-infective. It is also being investigated for the treatment of head and neck cancer.
== References ==
Excerpted from Wikipedia’s “nimorazole” article, available under the CC BY-SA 4.0 licence.
Available in 10 languages
via Wikidata sitelinks · CC0